Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex
Open Access
Abstract
COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), remains an ongoing global health challenge. This study analyzed 3641 SARS-CoV-2 positive samples from the El Paso, Texas, community and hospitalized patients over 48 weeks from Fall 2021 to Summer 2022. The binational community along the U.S. southern border was predominantly SARS-CoV-2 Delta variant (B.1.617.2) positive for a 5-week period from September 2021 to January 2022 and quickly transitioned to the Omicron variant (B.1.1.529), which was first detected at the end of December 2021. Omicron replaced Delta as the predominant detectable variant in the community and was associated with a sharp increase in COVID-19 positivity rate, related hospitalizations, and newly reported cases. In this study, Omicron BA.1, BA.4, and BA.5 variants were overwhelmingly associated with S-gene dropout by qRT-PCR analysis unlike the Delta and Omicron BA.2 variants. The study reveals that a dominant variant, like Delta, can be rapidly replaced by a more transmissible variant, like Omicron, within a dynamic metropolitan border city, necessitating enhanced monitoring, readiness, and response from public health officials and healthcare workers.Keywords
Funding Information
- National Institutes of Health (3U54MD007592-27S1)
This publication has 20 references indexed in Scilit:
- Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 VariantsmedRxiv, 2022
- Unusual N Gene Dropout and Ct Value Shift in Commercial Multiplex PCR Assays Caused by Mutated SARS-CoV-2 StrainDiagnostics, 2022
- SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- SARS-CoV-2 spike D614G change enhances replication and transmissionNature, 2021
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020Eurosurveillance, 2021
- StatPearls2021
- SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivoScience, 2020
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein VariantCell, 2020
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and AntigenicityCell, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020